We could not recruit individuals with mild or moderate COVID-19 since the study center is a tertiary-care hospital; therefore, the relevance of IFNAR2 in less severe COVID-19 or asymptomatic individuals requires further investigation. Here, IFNAR2 is linked to COVID-19.